Clinical trial
Imaging of Cannabinoid Receptors Using New Radioactive Tracer
NCT00450021 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00450021 |
|---|---|
| Title | Imaging of Cannabinoid Receptors Using New Radioactive Tracer |
| Official title | Imaging of Cannabinoid CB(1) Receptors Using [11C] MePPEP |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Collaborators | National Institute of Mental Health, Eli Lilly & Co. |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | [(11)C] MePPEP |
| Enrollment | 25 |
| Start date | Mar 19, 2007 |
| Primary completion | Feb 6, 2008 |
| First posted | Mar 21, 2007 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: